CIK 0001799788
- Non-accelerated filer
- Smaller reporting company
Greenwich LifeSciences, Inc.
Sign in to watch- Ticker
- GLSI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205473709
- Phone
- +1 203-434-3290
- Business address
- 3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, 77477
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-24 | Daugherty Frank Joseph Chief Medical Officer | Grant or award · Stock Options | +104,890 | 209,780 | ||
| 2022-06-22 | Daugherty Frank Joseph Chief Medical Officer | Grant or award · Stock Options | +104,890 | 104,890 | ||
| 2022-04-25 | Daugherty Frank Joseph Chief Medical Officer | Purchase | +1,000 | $16.25 | $16K | 90,121 |
| 2022-01-13 | Daugherty Frank Joseph Chief Medical Officer | Purchase | +1,000 | $19.99 | $20K | 89,121 |
| 2021-12-14 | Daugherty Frank Joseph Chief Medical Officer | Purchase | +1,111 | $26.99 | $30K | 88,121 |
| 2020-11-23 | Daugherty Frank Joseph Chief Medical Officer | Purchase | +1,000 | $5.10 | $5K | 87,010 |
| 2020-09-29 | Daugherty Frank Joseph Chief Medical Officer | Purchase | +1,739 | $5.75 | $10K | 86,010 |
Page 1 of 1 · 7 trades